Johnson & Johnson (JNJ)
(Real Time Quote from BATS)
$164.30 USD
-0.52 (-0.32%)
Updated Sep 20, 2024 12:32 PM ET
4-Sell of 5 4
C Value F Growth C Momentum D VGM
Earnings News For JNJ
-
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
-
Why Is Johnson & Johnson (JNJ) Up 2.4% Since Last Earnings Report?
-
J&J (JNJ) Q2 Earnings & Sales Top, EPS View Cut on M&A Costs
-
Johnson & Johnson (JNJ) Beats Q2 Earnings and Revenue Estimates
-
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
-
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
-
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
-
Johnson & Johnson (JNJ) Q1 Earnings Top Estimates
-
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
-
Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
-
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?
-
J&J's (JNJ) Q4 Earnings Beat, Darzalex, Stelara Drive Sales
-
J&J (JNJ) Gears Up to Report Q4 Earnings: What's in Store?
-
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
-
Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound?
-
J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off
-
Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass Estimates
-
J&J (JNJ) to Report Q3 Earnings, Its First After Unit Spin-Off
-
Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline
-
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
-
J&J (JNJ) Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps
-
Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates
-
J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector
-
Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth